» Articles » PMID: 8247009

Complementation by Wild-type P53 of Interleukin-6 Effects on M1 Cells: Induction of Cell Cycle Exit and Cooperativity with C-myc Suppression

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1993 Dec 1
PMID 8247009
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Stable transfection of M1 myeloid leukemia cells with a temperature-sensitive mutant of p53 results in two phenomena that are manifested exclusively at the permissive temperature. On one hand, activation of wild-type p53 by the temperature shift induced an apoptotic type of cell death which could be inhibited by interleukin-6 (IL-6) (E. Yonish-Rouach, D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren, Nature 352:345-347, 1991). On the other hand, as reported in this work, activated p53 complemented the antiproliferative effects of IL-6 in M1 cells. A shift to the permissive temperature concomitant with or early after IL-6 treatment imposed a novel pattern of cell cycle arrest in which about 95% of the cells were retained within a G0-like quiescent state. This phase was characterized by 2N DNA content and low RNA and protein content. On the molecular level, activation of wild-type p53 transrepressed the c-myc gene but not the cyclin A, D1, or D2 gene, which are all independently suppressed by IL-6 in M1 cells. To further analyze whether c-myc inhibition mediates or complements p53 effects, the p53-transfected M1 cells were infected with a retroviral vector expressing deregulated c-myc, refractory to p53 or IL-6 action. It was found that the process of cell death was not interrupted at all in these M1 c-myc-p53 double transfectants, suggesting that the transrepression of c-myc is not a major obligatory event mediating p53-induced cell death. In addition, some of the antiproliferative effects of activated p53, manifested in the presence of IL-6, could still be transmitted in the background of constitutive c-myc. Yet the context of deregulated c-myc interfered with the final accumulation of cells within a G0-like phase, suggesting complementary interactions between the outcome of p53 activation and of c-myc suppression in the control of cell cycle arrest.

Citing Articles

PTEN loss drives p53 LOH and immune evasion in a novel urothelial organoid model harboring p53 missense mutations.

Hamada A, Kita Y, Sakatani T, Nakamura K, Takada H, Ikeuchi R Oncogene. 2025; .

PMID: 39987272 DOI: 10.1038/s41388-025-03311-5.


Genome-wide characterization of DNA methyltransferase family genes implies GhDMT6 improving tolerance of salt and drought on cotton.

Yang X, Bai Z, He Y, Wang N, Sun L, Li Y BMC Plant Biol. 2024; 24(1):312.

PMID: 38649800 PMC: 11036760. DOI: 10.1186/s12870-024-04985-x.


Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression.

Ogunleye A, Nimmakayala R, Batra S, Ponnusamy M Stem Cells. 2023; 41(5):417-430.

PMID: 36869789 PMC: 10183971. DOI: 10.1093/stmcls/sxad017.


Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment.

Almeida J, Mota I, Skoda J, Sousa E, Cidade H, Saraiva L Cancers (Basel). 2022; 14(24).

PMID: 36551697 PMC: 9777536. DOI: 10.3390/cancers14246212.


Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration.

Greenberg J, Limberg J, Verma A, Kim D, Chen X, Lee Y JCI Insight. 2022; 7(23).

PMID: 36301668 PMC: 9746918. DOI: 10.1172/jci.insight.160130.


References
1.
Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteur P . Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985; 13(5):1431-42. PMC: 341087. DOI: 10.1093/nar/13.5.1431. View

2.
Kastan M, Onyekwere O, Sidransky D, Vogelstein B, Craig R . Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51(23 Pt 1):6304-11. View

3.
Yarden A, Kimchi A . Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells. Science. 1986; 234(4782):1419-21. DOI: 10.1126/science.3097823. View

4.
Pietenpol J, Stein R, Moran E, Yaciuk P, Schlegel R, Lyons R . TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 1990; 61(5):777-85. DOI: 10.1016/0092-8674(90)90188-k. View

5.
Morgenstern J, Land H . Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 1990; 18(12):3587-96. PMC: 331014. DOI: 10.1093/nar/18.12.3587. View